Ibritumomab is a protein that targets white blood cells in the body. When ibritumomab is
attached to a radioactive chemical, the radiation is delivered directly to the tumor (lymphoma).
Ibritumomab is used in combination with other medicines to treat non-Hodgkin's
lymphoma.
Ibritumomab may also be used for purposes other than those listed in this medication
guide.